<- Go Home

EBOS Group Limited

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; pharmacy data, consumer loyalty, and analytics services; and health communications, programs, and consultancy services. It also offers community-based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five-step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; dog and cat food, and treats; and surgical devices and medical consumables. Further, it provides pet nutrition, treats, clean-up, and grooming products and accessories; supplies pet medicines and other products to veterinary clinics and specialty retailers; manufactures and supplies dog rolls; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Market Cap

NZD 3.2B

Volume

268.3K

Cash and Equivalents

NZD 239.1M

EBITDA

NZD 466.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

NZD 1.7B

Profit Margin

12.93%

52 Week High

NZD 24.04

52 Week Low

NZD 14.83

Dividend

6.46%

Price / Book Value

1.15

Price / Earnings

13.99

Price / Tangible Book Value

-16.45

Enterprise Value

NZD 4.8B

Enterprise Value / EBITDA

8.50

Operating Income

NZD 378.0M

Return on Equity

8.33%

Return on Assets

3.13

Cash and Short Term Investments

NZD 252.5M

Debt

NZD 1.9B

Equity

NZD 2.7B

Revenue

NZD 13.5B

Unlevered FCF

NZD 215.8M

Sector

Health Care Providers and Services

Category

N/A

Company Stock Pitches